USA Financial Formulas’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,693
Closed -$516K 411
2020
Q4
$516K Sell
2,693
-1,261
-32% -$229K 0.41% 77
2020
Q3
$583K Buy
3,954
+1,107
+39% +$158K 0.44% 65
2020
Q2
$352K Buy
+2,847
New +$335K 0.26% 60
2019
Q4
Sell
-2,558
Closed -$196K 297
2019
Q3
$196K Buy
+2,558
New +$224K 0.08% 131
2019
Q1
Sell
-10,874
Closed -$603K 291
2018
Q4
$603K Buy
+10,874
New +$638K 0.15% 107

Other funds holding RGEN

USA Financial Formulas's RGEN Position: Q1 2021 in Review

USA Financial Formulas sold out of Repligen (RGEN) in Q1 2021, closing a stake of 2,693 shares — an estimated $516K sold.

USA Financial Formulas first reported a position in RGEN in Q4 2018 and held it in 5 quarters. The position peaked at $603K in Q4 2018. 458 funds tracked by Wall St. Rank hold RGEN as of Q1 2021.

  • USA Financial Formulas reported no remaining Repligen position as of Q1 2021 after selling out during the quarter.
  • USA Financial Formulas sold 2,693 Repligen shares in Q1 2021, an estimated $516K.
  • USA Financial Formulas first reported a position in Repligen in Q4 2018 and held it in 5 quarters.
  • USA Financial Formulas's Repligen position peaked at $603K in Q4 2018.
  • 458 funds tracked by Wall St. Rank held Repligen as of Q1 2021.

Based on USA Financial Formulas's 13F filing for Q1 2021, filed 6 May 2021.